GTF2H2 Protein

GTF2H2 Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GTF2H2 Protein</th>
</tr>
<tr>
<td class="label">Model</td>
<td>Design</td>
</tr>
<tr>
<td class="label">Gtf2h2 conditional KO in neurons</td>
<td>Cre-dependent deletion in excitatory neurons</td>
</tr>
<tr>
<td class="label">Gtf2h2 heterozygous mice</td>
<td>Partial loss-of-function</td>
</tr>
<tr>
<td class="label">Ner-deficient mouse models</td>
<td>Xpc-/-, Csb-/-, Ercc1-/ mice</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

General Transcription Factor IIH Subunit 2 (GTF2H2) is a 44 kDa protein that forms an essential core component of the TFIIH transcription factor complex, also known as the general transcription factor TFIIH. The TFIIH complex is a multi-subunit molecular machine (~500 kDa total) that plays a dual critical role in eukaryotic cells: it opens DNA during transcription initiation by RNA polymerase II (RNAPII) and it executes nucleotide excision repair (NER) pathway to remove bulky DNA lesions caused by UV radiation, oxidative damage, and chemical adducts[@egly2011]. GTF2H2 participates directly in both of these fundamental cellular processes through its structural and enzymatic roles within the complex.

GTF2H2 Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GTF2H2 Protein</th>
</tr>
<tr>
<td class="label">Model</td>
<td>Design</td>
</tr>
<tr>
<td class="label">Gtf2h2 conditional KO in neurons</td>
<td>Cre-dependent deletion in excitatory neurons</td>
</tr>
<tr>
<td class="label">Gtf2h2 heterozygous mice</td>
<td>Partial loss-of-function</td>
</tr>
<tr>
<td class="label">Ner-deficient mouse models</td>
<td>Xpc-/-, Csb-/-, Ercc1-/ mice</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

General Transcription Factor IIH Subunit 2 (GTF2H2) is a 44 kDa protein that forms an essential core component of the TFIIH transcription factor complex, also known as the general transcription factor TFIIH. The TFIIH complex is a multi-subunit molecular machine (~500 kDa total) that plays a dual critical role in eukaryotic cells: it opens DNA during transcription initiation by RNA polymerase II (RNAPII) and it executes nucleotide excision repair (NER) pathway to remove bulky DNA lesions caused by UV radiation, oxidative damage, and chemical adducts[@egly2011]. GTF2H2 participates directly in both of these fundamental cellular processes through its structural and enzymatic roles within the complex.

The human TFIIH complex is composed of 9 subunits organized into two sub-complexes: the core TFIIH (XPB, XPD, GTF2H2, GTF2H3, GTF2H4, GTF2H5, p34, p52) and the CDK-activating kinase (CAK) module (CDK7, Cyclin H, MAT1)[@egly2011]. GTF2H2 is one of the four core subunits that support the structural integrity and functional activity of the complex. GTF2H2 is closely related to GTF2H3, GTF2H4, and GTF2H5 — these four proteins form the so-called "p34/p44" subcomplex that stabilizes the core and facilitates the recruitment and function of the helicase subunits.

Given that post-mitotic neurons are uniquely dependent on DNA repair mechanisms throughout life, and that they possess high metabolic rates generating significant oxidative stress, GTF2H2's role in NER makes it a protein of considerable interest in neurodegeneration research. Deficiencies in NER capacity have been linked to premature neurodegeneration in humans (Cockayne syndrome, trichothiodystrophy) and in animal models, and several lines of evidence point to reduced NER efficiency in both [Alzheimer's Disease](/diseases/alzheimers-disease) (AD) and [Parkinson's Disease](/diseases/parkinsons-disease) (PD)[@chen2013].

Protein Structure

Primary Structure

GTF2H2 is a 395-amino acid protein with a molecular weight of approximately 44 kDa. The protein is organized into distinct structural domains:

N-terminal region (residues 1-100): A low-complexity region involved in protein-protein interactions with other TFIIH subunits, particularly p52 (GTF2E1). This region contains binding motifs for the p44/Ssl1 subunit.

Central domain (residues 100-300): The most structured portion of GTF2H2, containing a region with weak similarity to a RING finger-like motif and a beta-sheet domain that participates in the assembly of the core TFIIH subcomplex. This domain is essential for maintaining the structural integrity of the TFIIH complex.

C-terminal region (residues 300-395): A helical domain involved in stabilizing the interaction with the XPB helicase subunit. This region is critical for the proper positioning of the XPB ATPase within the complex.

Three-Dimensional Structure

The TFIIH core structure has been solved by cryo-EM at near-atomic resolution, revealing GTF2H2 as a horseshoe-shaped platform that positions the XPB and XPD helicases at opposite ends[@egly2011]. GTF2H2 forms part of the scaffold that bridges XPB and XPD, stabilizing their conformations and regulating their activities. The protein adopts a predominantly beta-strand fold in its central domain, with alpha-helical segments at the N- and C-termini.

GTF2H2 makes extensive contacts with XPB through its C-terminal domain, and with the p44 subunit through its N-terminal region. The p44/GTF2H2 interaction is particularly important because p44 contains an E3 ubiquitin ligase activity that modifies GTF2H2, regulating the balance between transcription and DNA repair functions of the complex[@komander2009].

Post-Translational Modifications

GTF2H2 undergoes several post-translational modifications that regulate its function within TFIIH:

Normal Physiological Functions

Role in Transcription Initiation

TFIIH is recruited to gene promoters by the MEDIATOR complex and other general transcription factors. Once at the promoter, TFIIH plays an essential role in opening the DNA double helix (melting the transcription bubble) through the ATP-dependent helicase activity of its XPB and XPD subunits. The XPB helicase (3'→5' direction) and XPD helicase (5'→3' direction) unwind approximately 15-30 base pairs of DNA around the transcription start site, creating the open complex that allows RNAPII to begin RNA synthesis.

GTF2H2 contributes to this process through its structural support of the XPB and XPD helicases[@egly2011]. Without GTF2H2, the XPB and XPD helicases are less stable within the complex, and their helicase activities are substantially reduced. The p44-mediated ubiquitination of GTF2H2 modulates this process: de-ubiquitinated GTF2H2 favors the transcriptionally active state, while ubiquitinated GTF2H2 promotes the DNA repair conformation.

Role in Nucleotide Excision Repair

GTF2H2's second major function is in NER, the versatile DNA repair pathway that removes a wide range of structurally diverse DNA lesions including UV-induced 6-4 photoproducts and cyclobutane pyrimidine dimers (CPDs), as well as adducts from environmental carcinogens and oxidative damage products.

NER operates through a stepwise mechanism[@egly2011]:

GTF2H2 supports the TFIIH-mediated steps of NER, particularly the helicase-driven DNA opening that precedes the dual incision. Mutations in XPB and XPD that impair TFIIH's DNA repair function cause severe human diseases with pronounced neurodegeneration (Cockayne syndrome, xeroderma pigmentosum)[@chen2013], demonstrating the critical importance of this function for neuronal survival.

Neuronal Functions

In [neurons](/entities/neurons), the TFIIH complex and therefore GTF2H2 participate in the expression of a broad spectrum of genes essential for neuronal function, including:

• Neurotransmitter receptors (glutamate receptors, GABA receptors, dopamine receptors)
• Ion channels (voltage-gated calcium channels, potassium channels)
• Synaptic proteins (SNAP25, synaptophysin, PSD-95)
• Transcription factors required for neuronal identity and survival (NRF1, REST)
• Mitochondrial genes critical for energy production in highly metabolic neurons

Role in Neurodegenerative Diseases

Alzheimer's Disease

Multiple independent lines of evidence implicate impaired NER in AD pathogenesis[@jacobson2012]:

Reduced NER capacity: Studies of AD brain tissue have demonstrated reduced NER efficiency compared to age-matched controls. Fibroblasts and lymphoblasts from AD patients show elevated sensitivity to UV-induced DNA damage, indicating a deficiency in the NER pathway. Patient-derived iPSC neurons from AD subjects show impaired DNA repair capacity when challenged with DNA-damaging agents[@chen2019].

Oxidative DNA damage accumulation: AD is associated with extensive oxidative stress, generating 8-oxoguanine (8-oxoG) lesions in DNA. NER is the primary pathway for removing 8-oxoG from the genome, and impaired NER leads to accumulation of this mutagenic lesion. The brain is particularly vulnerable because it consumes ~20% of the body's oxygen despite being only 2% of body mass.

TFIIH dysfunction in AD: Several studies have reported reduced expression or activity of TFIIH subunits in AD brain. The GTF2H2 promoter region may be subject to epigenetic silencing in AD, contributing to reduced TFIIH levels. A consequence of reduced TFIIH is diminished transcription of neuronal maintenance genes and impaired NER[@jacobson2012].

Transcription dysregulation: AD brains show widespread transcriptional dysregulation, including reduced expression of mitochondrial genes, synaptic proteins, and neuronal survival factors. The TFIIH complex sits at the nexus of transcription, and any impairment contributes to this transcriptional collapse[@lu2014].

Parkinson's Disease

NER deficiency has also been implicated in PD pathogenesis[@rao2018;@chang2018]:

Environmental toxin susceptibility: Epidemiological studies have associated pesticide exposure with increased PD risk. Many pesticides (including paraquat and rotenone) generate oxidative DNA damage that requires NER for repair. Individuals with suboptimal NER capacity may be more susceptible to environmentally induced PD.

Mitochondrial dysfunction intersection: PD is strongly linked to mitochondrial dysfunction (evidenced by MPTP, rotenone, and 6-OHDA models, and by PINK1/PARKIN mutations). Impaired mitochondria generate excess ROS, increasing oxidative DNA damage burden. Simultaneously, NER capacity declines with age, creating a "double hit" scenario where neurons accumulate DNA damage beyond repair capacity.

Alpha-synuclein and DNA repair: Alpha-synuclein ([αSyn](/proteins/alpha-synuclein)) has been reported to interact with DNA repair proteins including PARP1 and XRCC1. Overexpression of αSyn in cellular models reduces NER efficiency, potentially by sequestering repair factors into aggregates or by interfering with their recruitment to damaged sites.

Dopaminergic neuron vulnerability: The substantia nigra pars compacta (SNpc) dopaminergic neurons that die in PD are particularly vulnerable to oxidative stress and DNA damage, partly because they have high metabolic rates, high iron content, and relatively low antioxidant defenses compared to other neuronal populations.

Role in Other Neurodegenerative Conditions

Cockayne Syndrome: This devastating progeroid syndrome features severe neurodegeneration, growth failure, and premature aging caused by mutations in NER genes (CSA/ERCC8, CSB/ERCC6, XPB, XPD, XPG)[@liu2015]. Cockayne syndrome neurons are hypersensitive to transcription-blocking DNA lesions and fail to properly resume transcription after DNA repair, leading to neuronal death. GTF2H2 mutations that impair the XPB-XPD-GTF2H2 interface would likely produce a similar phenotype.

Trichothiodystrophy (TTD): Caused by mutations in TFIIH subunits (including TTD-A/GTF2H5, XPB, XPD), TTD features brittle hair, growth failure, and progressive neurodegeneration with intellectual disability[@takashima2012]. The neurological involvement in TTD directly implicates TFIIH dysfunction in neuronal loss.

Age-Related Cognitive Decline: Even in the absence of frank neurodegeneration, normal aging is associated with declining NER capacity and accumulation of DNA damage in the brain. This decline may contribute to age-related cognitive impairment and represents a therapeutic target for healthy aging.

Therapeutic Implications

Enhancing DNA Repair Capacity

Small molecule NER enhancers: Several compounds that boost NER capacity are in development for neurodegenerative conditions, including:

• Carboxymethyl-lysine (CML) derivatives that upregulate NER gene expression
• HDAC inhibitors (e.g., sodium butyrate, TSA) that enhance transcription of DNA repair genes
• PARP inhibitors that redirect cellular resources toward NER

Neuroprotection Through Transcription Support

Since TFIIH is required for expression of neuronal survival genes, enhancing TFIIH function could help maintain neuronal health in the face of disease-related transcriptional decline. Gene therapy approaches to increase GTF2H2 expression in specific neuronal populations are speculative but theoretically possible.

Animal Models

Cross-References

Related Proteins

• [TFIIH Complex (XPB/XPD)](/genes/xpb) — Other core TFIIH helicase subunits
• [XPC Protein](/proteins/xpc) — Key NER damage recognition factor
• [XPA Protein](/proteins/xpa) — NER verification factor

Related Mechanisms

• [DNA Damage Response](/mechanisms/dna-damage-response) — DNA repair pathways in neurons
• [Transcription Dysregulation in Neurodegeneration](/mechanisms/transcription-dysregulation) — TFIIH and transcriptional control
• [Oxidative Stress in Neurodegeneration](/mechanisms/oxidative-stress) — Relationship between ROS, DNA damage, and NER
• [NER and Transcription Coupling](/mechanisms/transcription-coupled-repair) — TC-NER pathway in post-mitotic neurons

Related Diseases

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Cockayne Syndrome](/diseases/cockayne-syndrome)
• [Trichothiodystrophy](/diseases/trichothiodystrophy)
• [GTF2H2 Gene](/genes/gtf2h2)
• [TFIIH Complex](/mechanisms/transcription-coupled-repair)
• [DNA Damage Response](/mechanisms/dna-damage-response)

See Also

• [DNA Repair Mechanisms](/mechanisms/dna-damage-response)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

References